Jump Financial’s Direxion Daily S&P Biotech Bear 3X ETF LABD Stock Holding History
Bought
Maintained
Sold
Other funds holding LABD
IC
CCM
CF
GS
Jump Financial's LABD Position: Q1 2026 in Review
Jump Financial sold out of Direxion Daily S&P Biotech Bear 3X ETF (LABD) in Q1 2026, closing a stake of 140,817 shares — an estimated $2.97M sold.
Jump Financial first reported a position in LABD in Q2 2022 and held it in 11 quarters. The position peaked at $7.37M in Q3 2023. 17 funds tracked by Wall St. Rank hold LABD as of Q1 2026.
- Jump Financial reported no remaining Direxion Daily S&P Biotech Bear 3X ETF position as of Q1 2026 after selling out during the quarter.
- Jump Financial sold 140,817 Direxion Daily S&P Biotech Bear 3X ETF shares in Q1 2026, an estimated $2.97M.
- Jump Financial first reported a position in Direxion Daily S&P Biotech Bear 3X ETF in Q2 2022 and held it in 11 quarters.
- Jump Financial's Direxion Daily S&P Biotech Bear 3X ETF position peaked at $7.37M in Q3 2023.
- 17 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bear 3X ETF as of Q1 2026.
Based on Jump Financial's 13F filing for Q1 2026, filed 14 May 2026.